Colorectal cancer (CRC) is one of the costliest health problems and ranks second in cancer-
related mortality in developed countries. With the aid of proteomics, many protein …

MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are two relevant classes of non-
coding RNAs (ncRNAs) that play a pivotal role in a number of molecular processes through …

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal type of cancer and the third
leading cause of cancer death with the lowest 5-year survival rate. Heterogeneity, difficulty in …

The lack of specific and sensitive early diagnostic options for pancreatic cancer (PC) results
in patients being largely diagnosed with late-stage disease, thus inoperable and burdened …

Sunitinib is the first‐line drug for renal cell carcinoma (RCC) treatment. However, patients
who received sunitinib treatment will ultimately develop drug resistance after 6–15 months …

Over the past decades, the aberrant epigenetic modification, apart from genetic alteration,
has emerged as dispensable events mediating the transformation of pancreatic cancer (PC) …

Pancreatic cancer is a malignancy arising from the endocrine or exocrine compartment of
this organ. Tumors from exocrine origin comprise over 90% of all pancreatic cancers …

Pancreatic ductal adenocarcinoma (PDAC) is poised to become the second leading cause
of cancer-related death by 2030, necessitating innovative therapeutic strategies. Genetic …

Abstract “Heterogeneity” in tumor mass has immense importance in cancer progression and
therapy. The impact of tumor heterogeneity is an emerging field and not yet fully explored …

Background Oral squamous cell carcinoma (OSCC) is a frequently-diagnosed malignancy
with high potential for proliferation and invasion. Histone methylation is known as a crucial …